loadpatents
name:-0.068228960037231
name:-0.028474092483521
name:-0.019407987594604
Hoffmann; Patrick Patent Filings

Hoffmann; Patrick

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hoffmann; Patrick.The latest application filed is for "binding molecules for bcma and cd3".

Company Profile
19.26.57
  • Hoffmann; Patrick - Munich DE
  • Hoffmann; Patrick - Ludwigsburg DE
  • HOFFMANN; Patrick - Bad Heilbrunn DE
  • Hoffmann; Patrick - Munchen N/A DE
  • Hoffmann; Patrick - Penzberg DE
  • Hoffmann; Patrick - Villons-les-Buissons FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibody constructs for FLT3 and CD3
Grant 11,447,567 - Raum , et al. September 20, 2
2022-09-20
Bispecific T cell engaging antibody constructs
Grant 11,434,302 - Raum , et al. September 6, 2
2022-09-06
Binding Molecules For Bcma And Cd3
App 20220251243 - Kufer; Peter ;   et al.
2022-08-11
BCMA and CD3 bispecific T cell engaging antibody constructs
Grant 11,352,433 - Raum , et al. June 7, 2
2022-06-07
Method for the automated assessment of a simulation model
App 20220171901 - Von Keler; Johannes ;   et al.
2022-06-02
Method For Treating Glioblastoma Or Glioma With Anitbody Constructs Egfrviii And Cd3
App 20220064308 - Raum; Tobias ;   et al.
2022-03-03
Binding Molecules For Bcma And Cd3
App 20220064336 - Kufer; Peter ;   et al.
2022-03-03
Cross-species-specific Single Domain Bispecific Single Chain Antibody
App 20220041736 - Kufer; Peter ;   et al.
2022-02-10
Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3
Grant 11,155,629 - Raum , et al. October 26, 2
2021-10-26
Antibody Constructs For Dll3 And Cd3
App 20210309743 - Raum; Tobias ;   et al.
2021-10-07
Antibody Constructs For Cd70 And Cd3
App 20210284748 - Raum; Tobias ;   et al.
2021-09-16
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
App 20210277143 - KUFER; Peter ;   et al.
2021-09-09
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
App 20210269550 - KUFER; Peter ;   et al.
2021-09-02
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains
Grant 11,084,876 - Kufer , et al. August 10, 2
2021-08-10
Bispecific antibody constructs for CDH3 and CD3
Grant 11,028,171 - Weiss , et al. June 8, 2
2021-06-08
PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs
App 20210070878 - Raum; Tobias ;   et al.
2021-03-11
Antibody constructs for CD70 and CD3
Grant 10,851,170 - Raum , et al. December 1, 2
2020-12-01
Cross-species-specific Pscaxcd3, Cd19xcd3, C-metxcd3, Endosialinxcd3, Epcamxcd3, Igf-1rxcd3 Or Fapalphaxcd3 Bispecific Single Chain Antibody
App 20200362039 - Kufer; Peter ;   et al.
2020-11-19
Antibody Constructs For Dll3 And Cd3
App 20200332002 - Raum; Tobias ;   et al.
2020-10-22
PSMA and CD3 bispecific T cell engaging antibody constructs
Grant 10,781,264 - Raum , et al. Sept
2020-09-22
Binding molecules for BCMA and CD3
Grant 10,766,969 - Kufer , et al. Sep
2020-09-08
Binding molecules for BCMA and CD3
Grant 10,752,694 - Kufer , et al. A
2020-08-25
Antibody constructs for DLL3 and CD3
Grant 10,683,351 - Raum , et al.
2020-06-16
Antibody Constructs For Egfrviii And Cd3
App 20200140558 - Raum; Tobias ;   et al.
2020-05-07
Cross-species-specific Bispecific Binders
App 20200095319 - Kufer; Peter ;   et al.
2020-03-26
Antibody Constructs For Cdh19 And Cd3
App 20200071405 - Xiao; Shouhua ;   et al.
2020-03-05
Bcma And Cd3 Bispecific T Cell Engaging Antibody Constructs
App 20200048357 - Raum; Tobias ;   et al.
2020-02-13
Single chain binding molecules comprising N-terminal ABP
App 20200040099 - Kufer; Peter ;   et al.
2020-02-06
Antibody constructs for EGFRVIII and CD3
Grant 10,519,241 - Raum , et al. Dec
2019-12-31
Antibody Constructs For Dll3 And Cd3
App 20190263907 - Raum; Tobias ;   et al.
2019-08-29
Long Life Polypeptide Binding Molecules
App 20190169295 - Kufer; Peter ;   et al.
2019-06-06
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
App 20190169310 - Kufer; Peter ;   et al.
2019-06-06
BCMA and CD3 bispecific T cell engaging antibody constructs
Grant 10,301,391 - Raum , et al.
2019-05-28
Antibody constructs for DLL3 and CD3
Grant 10,294,300 - Raum , et al.
2019-05-21
Antibody Constructs For Cdh19 And Cd3
App 20190016805 - Xiao; Shouhua ;   et al.
2019-01-17
Antibody constructs for CDH19 and CD3
Grant 10,059,766 - Xiao , et al. August 28, 2
2018-08-28
Bispecific Antibody Constructs For Cdh3 And Cd3
App 20180142021 - Weiss; Bertram ;   et al.
2018-05-24
Antibody Constructs For CDH19 and CD3
App 20180002450 - Xiao; Shouhua ;   et al.
2018-01-04
Optimized Cross-species Specific Bispecific Single Chain Antibody Contructs
App 20170349668 - Rattel; Benno ;   et al.
2017-12-07
Anti-Leukocyte Adhesion for the Mitigation of Potential Adverse Events Caused by CD3-Specific Binding Domains
App 20170327581 - Kufer; Peter ;   et al.
2017-11-16
Bispecific Single Chain Antibody Construct With Enhanced Tissue Distribution
App 20170275373 - Kufer; Peter ;   et al.
2017-09-28
Antibody constructs for CDH19 and CD3
Grant 9,765,157 - Xiao , et al. September 19, 2
2017-09-19
PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs
App 20170218079 - Raum; Tobias ;   et al.
2017-08-03
Bcma And Cd3 Bispecific T Cell Engaging Antibody Constructs
App 20170218077 - Raum; Tobias ;   et al.
2017-08-03
Bispecific T Cell Engaging Antibody Constructs
App 20170218078 - Raum; Tobias ;   et al.
2017-08-03
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains
Grant 9,688,760 - Kufer , et al. June 27, 2
2017-06-27
Antibody Constructs For Cd70 And Cd3
App 20170129961 - Raum; Tobias ;   et al.
2017-05-11
Binding molecules for BCMA and CD3
Grant 9,598,500 - Kufer , et al. March 21, 2
2017-03-21
Cross-species-specific PSMAxCD3 bispecific single chain antibody
Grant 9,587,036 - Kufer , et al. March 7, 2
2017-03-07
Antibody Constructs For Flt3 And Cd3
App 20170037149 - Raum; Tobias ;   et al.
2017-02-09
Antibody Constructs For Dll3 And Cd3
App 20170037130 - Raum; Tobias ;   et al.
2017-02-09
Antibody Constructs For Msln And Cd3
App 20170029502 - Raum; Tobias ;   et al.
2017-02-02
Antibody Constructs For Egfrviii And Cd3
App 20170029512 - Raum; Tobias ;   et al.
2017-02-02
PPS for the prevention of potential adverse effects caused by CD3 specific binding domains
Grant 9,486,475 - Kufer , et al. November 8, 2
2016-11-08
Binding Molecules For Bcma And Cd3
App 20160176973 - Kufer; Peter ;   et al.
2016-06-23
Cross-species-specific Bispecific Binders
App 20160152707 - Kufer; Peter ;   et al.
2016-06-02
Binding molecules for BCMA and CD3
Grant 9,340,621 - Kufer , et al. May 17, 2
2016-05-17
Single Chain Binding Molecules Comprising N-terminal Abp
App 20160122436 - Kufer; Peter ;   et al.
2016-05-05
Antibody constructs for CDH19 and CD3
App 20160032019 - Xiao; Shouhua ;   et al.
2016-02-04
Antibody Constructs For Cdh19 And Cd3
App 20150368343 - Xiao; Shouhua ;   et al.
2015-12-24
Binding molecules for BCMA and CD3
Grant 9,150,664 - Kufer , et al. October 6, 2
2015-10-06
Long Life Polypeptide Binding Molecules
App 20150037334 - Kufer; Peter ;   et al.
2015-02-05
Binding Molecules For Bcma And Cd3
App 20150023967 - Kufer; Peter ;   et al.
2015-01-22
Binding Molecules For Bcma And Cd3
App 20140348837 - Kufer; Peter ;   et al.
2014-11-27
Antibody Constructs for CDH19 and CD3
App 20140322218 - Xiao; Shouhua ;   et al.
2014-10-30
Anti-Leukocyte Adhesion for the Mitigation of Potential Adverse Events caused by CD3-Specific Binding Domains
App 20140227272 - Kufer; Peter ;   et al.
2014-08-14
PPS for the prevention of potential adverse effects caused by CD3 specific binding domains
App 20140228316 - Kufer; Peter ;   et al.
2014-08-14
Expression-enhanced polypeptides
Grant 8,518,403 - Hoffmann , et al. August 27, 2
2013-08-27
Binding Molecules For Bcma And Cd3
App 20130156770 - Kufer; Peter ;   et al.
2013-06-20
Binding Molecules For Bcma And Cd3
App 20130156769 - Kufer; Peter ;   et al.
2013-06-20
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
App 20130129730 - Kufer; Peter ;   et al.
2013-05-23
Cross-species-specific Bispecific Binders
App 20120244162 - KUFER; Peter ;   et al.
2012-09-27
CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
App 20120034228 - Kufer; Peter ;   et al.
2012-02-09
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
App 20110293619 - Kufer; Peter ;   et al.
2011-12-01
Cross-species-specific Bispecific Binders
App 20100183615 - Kufer; Peter ;   et al.
2010-07-22
Cross-species-specific Binding Domain
App 20100150918 - Kufer; Peter ;   et al.
2010-06-17
Expression-enhanced Polypeptides
App 20090053223 - Hoffmann; Patrick ;   et al.
2009-02-26
Use of Activated Polymers for Separation of Protein and Polypeptide Multimers
App 20080312411 - Wolf; Andreas ;   et al.
2008-12-18
Electrodynamic acoustic transducer
Grant 7,426,281 - Hoffmann September 16, 2
2008-09-16
Electrodynamic acoustic transducer
App 20060147076 - Hoffmann; Patrick
2006-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed